These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33043676)

  • 21. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
    Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
    Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
    Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
    Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.
    Cheng CW; Li LH; Su CY; Li SY; Yen MY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):708-716. PubMed ID: 25442864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and meta-analysis on efficacy of cefixime for treating gonococcal infections.
    Tanvir SB; Qasim SSB; Shariq A; Najeeb S; Shah AH
    Int J Health Sci (Qassim); 2018; 12(5):90-100. PubMed ID: 30202413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quick recertification series. Gonorrhea.
    Klingler A
    JAAPA; 2010 Nov; 23(11):56. PubMed ID: 21086893
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
    Workneh M; Hamill MM; Kakooza F; Mande E; Wagner J; Mbabazi O; Mugasha R; Kajumbula H; Walwema R; Zenilman J; Musinguzi P; Kyambadde P; Lamorde M; Manabe YC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17009. PubMed ID: 32519969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    Ayinde O; Ross JDC; Jackson L
    PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis.
    Yang J; Dhital S; Naderer T
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31835724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea.
    Barbee LA; Kerani RP; Dombrowski JC; Soge OO; Golden MR
    Clin Infect Dis; 2013 Jun; 56(11):1539-45. PubMed ID: 23408680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
    McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
    Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
    Mogabgab WJ; Lutz FB
    South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.
    Handsfield HH; Dalu ZA; Martin DH; Douglas JM; McCarty JM; Schlossberg D
    Sex Transm Dis; 1994; 21(2):107-11. PubMed ID: 9071422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
    van Amerongen R; Gazendam RP; van Bergen JEAM
    BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate hypersensitivity reaction to single-dose parenteral ceftriaxone therapy for gonorrhea.
    Zishka PA; Douglas JM
    Sex Transm Dis; 1991; 18(1):26-7. PubMed ID: 2028365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
    Owens RC; Tessier P; Nightingale CH; Ambrose PG; Quintiliani R; Nicolau DP
    Int J Antimicrob Agents; 2001 Jun; 17(6):483-9. PubMed ID: 11397619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis/cervicitis.
    Mogabgab WJ
    Am J Med; 1991 Dec; 91(6A):145S-149S. PubMed ID: 1662885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.